Patents by Inventor James McRea

James McRea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070259901
    Abstract: The present invention relates to pharmaceutical compositions and dosage compositions of compounds, including injectable formulations for the parenteral delivery of such compounds into patients in need of such treatment. Also featured are methods of making and using the compositions, including methods for the treatment of neoplastic diseases.
    Type: Application
    Filed: April 10, 2007
    Publication date: November 8, 2007
    Applicant: Myriad Genetics, Incorporated
    Inventors: Gaylen Zentner, Chung Shih, James McRea
  • Publication number: 20070249640
    Abstract: The present invention relates to pharmaceutical compositions and dosage compositions of compounds, including injectable formulations for the parenteral delivery of such compounds into patients in need of such treatment. Also featured are methods of making and using the compositions, including methods for the treatment of neoplastic diseases.
    Type: Application
    Filed: March 2, 2007
    Publication date: October 25, 2007
    Applicant: Myriad Genetics, Incorporated
    Inventors: Gaylen Zentner, Chung Shih, James McRea
  • Publication number: 20070249632
    Abstract: The present invention relates to pharmaceutical compositions and dosage compositions of compounds, including injectable formulations for the parenteral delivery of such compounds into patients in need of such treatment. Also featured are methods of making and using the compositions, including methods for the treatment of neoplastic diseases.
    Type: Application
    Filed: March 28, 2007
    Publication date: October 25, 2007
    Applicant: Myriad Genetics, Incorporated
    Inventors: Gaylen Zentner, Chung Shih, James McRea
  • Publication number: 20070042034
    Abstract: The invention relates to high drug load formulations containing (R)-2-(2-fluoro-4-biphenylyl)propionic acid as an active pharmaceutical ingredient.
    Type: Application
    Filed: July 24, 2006
    Publication date: February 22, 2007
    Applicant: Myriad Genetics, Incorporated
    Inventors: Gaylen Zentner, James McRea, Mark Williams, Gregory Oehrtman, Tracy Powers